APIC 2015 was a success! It was great to see many familiar faces, as well as new ones, at the show this year. It’s no surprise that infection prevention is an absolutely necessary focus for health care institutions now, so we were glad to hear people asking how measured dose UVC disinfection fits into their particular facility’s environment and workflow routines.
Additionally, there was a great turnout for the pre-conference workshop “Disinfection, Sterilization, and Antisepsis: Principles, Practices, Current Issues, New Research and New Technologies” led by Dr. William A. Rutala. And, the crowd wasn’t disappointed! Rutala and many other leading researchers in infection prevention shared new findings and important takeaways for the year ahead.
During the conference, discussions made it clear that many are counting down to the release of the results for the Benefits of Enhanced Terminal Room Disinfection study performed by the Duke Infection Control Outreach Network. And we are, too! These groundbreaking results will give the most comprehensive analysis of UV disinfection efficacy in real-world settings. Tru-D’s exclusive selection in the $2 million study, which was funded by the Centers for Disease Prevention and Control, resulted in an epidemiologically correct double-blind data pool inclusive of 25,000 room disinfection cycles and 100,000 patient days in 10 hospitals of varying size and census. This vast data pool allowed for the exclusion of confounding factors and conflicts of interest related to the current literature available, making the real-world results of this study the first of its kind.
APIC 2015 made it clear that infection prevention is only to increase in importance, and we’re looking forward to another year of innovation and proven results with our partners in the industry.